NCT00447070 Effect of Atazanavir on Endothelial Function in HIV-Infected Patients Status COMPLETED Phase PHASE4
NCT00444678 Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00444015 Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE1
NCT00442611 A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma) Status COMPLETED Phase PHASE1/PHASE2
NCT00441337 A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies Status COMPLETED Phase PHASE1
NCT00439608 Cetuximab, Paclitaxel, Carboplatin & Radiation for Esoph, Gastroesoph & Gastric Cancer Status COMPLETED Phase PHASE2
NCT00439270 Study of Dasatinib and Docetaxel in Metastatic Hormone Refractory Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00437437 A Phase I Study to Determine the Effect of Food on Brivanib (BMS-582664) Status COMPLETED Phase PHASE1
NCT00437424 A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver Dysfunction Status COMPLETED Phase PHASE1
NCT00435669 A Phase I Study to Determine Absorption, Distribution, Metabolism, and Elimination of a Single Radiolabeled Dose of Brivanib (BMS-582664) Status COMPLETED Phase PHASE1
NCT00430677 Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis Status TERMINATED Phase PHASE2/PHASE3
NCT00430027 Preoperative Capecitabine, Oxaliplatin, Cetuximab, and Radiation Therapy for Locally Advanced Esophageal Adenocarcinoma Status TERMINATED Phase NA
NCT00423891 A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection Status COMPLETED Phase PHASE1/PHASE2
NCT00423319 Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3) Status COMPLETED Phase PHASE3
NCT00420199 A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate Status COMPLETED Phase PHASE3
NCT00420186 A Phase I Study of BMS-690514 in Combination With Paclitaxel and Carboplatin Status COMPLETED Phase PHASE1